LINC wants to automate your supplements. Here is the harder problem.

Open the cabinet where you keep your supplements and take an honest inventory. The magnesium you bought for better sleep, taken for nine days. The fish oil, half full since spring. The greens powder you do not mention to anyone. Almost everyone who buys supplements ends up with this small graveyard, and it is the exact problem a new company called LINC believes it can automate out of existence.

LINC, pitched by its makers as the WHOOP of nutrition, is a countertop machine that dispenses a personalized supplement drink at the press of a button and quietly adjusts what goes into it based on your data. It is a genuinely clever idea. It is also, right now, a promise rather than a product, and the space between those two things happens to explain almost everything that is wrong with the supplement industry it wants to fix.

What LINC actually is

Strip away the launch language and LINC is three things working together: a connected device that sits on your counter, a set of smart cartridges of ingredients, and an app. Instead of a fistful of pills, it mixes a single drink. An AI the company calls Autopilot decides the daily dose of what LINC describes as dozens of vitamins, minerals, adaptogens and electrolytes, and nudges it over time. LINC says its ingredients are clinically studied, third-party tested, fully transparent, with no proprietary blends or underdosed formulas, and that doses stay within clinically informed safety ranges. Those are the right promises to make. They are also, for now, promises, because there is no product on the market to test them against.

One correction is worth making up front, because it sits at the heart of the pitch. LINC does not measure your biomarkers. It reads a questionnaire you fill in and the data from a wearable, your sleep, recovery and activity synced from WHOOP, Oura or Apple Health, and adjusts the blend from there. The company says the system is designed to integrate blood work in future, but that is a roadmap, not a feature you can use today, and a wearable is not even required. So the promise of a machine reading your biology is, at launch, closer to your sleep score plus a survey than your bloodstream.

The problem it is built for is real

Start with what LINC gets right, because it gets the diagnosis right. Consistency is where supplements quietly fail. The evidence on taking anything daily is unforgiving: adherence drops as the routine gets more complicated, from roughly four in five people managing a simple once-a-day habit down to about half when the schedule turns into a four-times-a-day chore. A machine that turns a shelf of bottles into one press of a button is a rational answer to that friction.

Here honesty cuts slightly against the pitch, though. The people who actually buy supplements are more consistent than the marketing implies. In a large national survey, about two-thirds of adult supplement users were highly adherent to at least one product, and four in ten had been taking supplements for more than five years. The friction LINC removes is real for the wafflers and the forgetful. For the already-committed, it is solving a problem they mostly do not have.

The harder problem: does any of it work?

Automating consistency answers the second question before the first. The first question is whether the thing you are being consistent about does anything, and here the supplement industry has a much older, much larger problem than friction.

Start with the rules. In the United States, supplements are governed by a 1994 law under which, in the FDA's own words, the agency does not approve dietary supplements before they are marketed. Manufacturers police their own safety and their own claims. The reassuring-sounding statements on the label, the ones about supporting energy or focus or immunity, are structure-function claims that no regulator reviewed, which is why they sit beside the quiet disclaimer that the FDA has not evaluated them. This is a 209 billion dollar industry that grades its own homework.

Then the evidence. In 2022, the US Preventive Services Task Force recommended against beta-carotene and vitamin E for preventing heart disease or cancer, and found the evidence simply insufficient to recommend multivitamins for that purpose. A decade earlier, a group of doctors put it less diplomatically in a journal editorial titled Enough Is Enough: Stop Wasting Money on Vitamin and Mineral Supplements. That is not the whole story, in fairness. A large randomized trial called COSMOS found a daily multivitamin modestly improved memory in older adults, which is a real result worth respecting. But the honest summary is that for most healthy, well-fed people, the case that a general daily stack changes hard health outcomes is weak.

Where supplements genuinely earn their place is narrower and more boring: correcting an actual deficiency. Vitamin D when you are deficient, B12 if you are vegan or older, folic acid in pregnancy, which the same task force rates a top-tier Grade A recommendation, iron when you are anemic. These are targeted tools for identified gaps, sold to everyone as general wellness. That gap between what works and what is marketed is the industry's actual disease.

Does personalization change the math?

LINC's real bet is that personalization is the fix, that tuning the blend to you is what finally makes it work. It is a lovely theory with almost no evidence behind it, at least for supplements. No robust trial has shown that tailoring a supplement blend to your data improves a health outcome you can feel. The strongest personalized-nutrition research is about food, not pills, and even there it is modest: a well-run trial of the ZOE method improved triglycerides but not LDL cholesterol against standard advice, and other biomarker-based programs, like PREVENTOMICS, found no added benefit over ordinary guidance at all.

There is a further wrinkle for anyone banking on the blood-work future LINC describes. Doctors have grown openly wary of the wider boom in consumer self-testing, warning that more numbers without clinical context mostly produces overtesting, false alarms and anxiety, not better decisions. A machine confidently dosing you against a panel of markers is only as good as the science connecting those markers to what you should actually swallow, and for most of them, that science is thin.

And the same rules still apply

One last thing personalization does not change: the cartridges are still supplements, under the same self-policed rules as everything else on the shelf. That shelf has a documented quality problem. In a 2015 investigation, the New York Attorney General found that only about one in five store-brand herbal supplements tested actually contained the plant on the label, though the DNA method used was later disputed by scientists who argued processing destroys the very DNA it looked for. More recent third-party testing keeps finding the same shape of problem, including popular products with little or none of their headline ingredient. LINC promises to be better than this, with third-party testing and honest doses, and it may well be. But a slick interface does not exempt a cartridge from the regulatory gap. It just makes the gap look premium.

So should you want one?

The idea is good and the instincts are right. If LINC ships what it describes, cleanly dosed, independently tested, transparent about what is inside, that genuinely beats a lot of what is on the shelf today, and the friction it removes is real. As a product, it is worth watching.

But it answers the easy question first. Making it effortless to take a daily blend only matters if the blend does something, and for most healthy people who are not deficient in anything, the evidence that it does is slim. Being perfectly, automatically consistent with an unproven mix just means reliably drinking things that may not help, on a subscription. The honest use for a machine like LINC is the same as for any supplement: fix a real gap you have actually identified, ideally one a doctor confirmed, rather than optimize a body that is already fine. When it launches, the questions worth asking are simple. Does independent testing back the quality claims? Does it push products onto people who do not need them? And does the blood-work integration ever become real, or stay a line in the pitch?

What we still do not know, said plainly: whether LINC's shipping product will match its promises, because it does not exist yet, and whether tuning a supplement blend to a wearable improves anything a person can feel. When LINC launches and independent testing exists, this article will change with it, logged in the updates section below.